Patent · US Active

Substituted imidazopyrazines as Akt kinase inhibitors

US9260435B2 · kind B2 · utility

0Cited by

0References

8Claims

0Family size

Assignee

Bayer Pharma Aktiengesellschaft · DE

Inventors

Lars Bärfacker · Oberhausen, DE
William Scott · Guilford, US
Andrea Hägebarth · Berlin, DE
Stuart Ince · Berlin, DE
Hartmut Rehwinkel · Berlin, DE
Oliver Politz · Panketal, DE
Roland Neuhaus · Berlin, DE
Ulf Bömer · Glienicke, DE

Key dates

Filing date	Jan 8, 2013
Grant date	Feb 16, 2016
Priority date	—
Expiry date	Jan 8, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I)which are effective inhibitors of the Pi3K/Akt pathway, processes for their production and their use as pharmaceuticals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.